Dyne Therapeutics (DYN) Shares Outstanding (Diluted) (2021 - 2026)
Powered by 
Analysis
Dyne Therapeutics (DYN) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Dyne Therapeutics | 4.04 Bn | 4.04 Bn | - | 165.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165.45 Mn |
| Mar 31, 2026 | 165.04 Mn |
| Dec 31, 2025 | 128.44 Mn |
| Sep 30, 2025 | 141.81 Mn |
| Jun 30, 2025 | 113.87 Mn |
| Mar 31, 2025 | 109.91 Mn |
| Dec 31, 2024 | 94.14 Mn |
| Sep 30, 2024 | 100.88 Mn |
| Jun 30, 2024 | 92.51 Mn |
| Mar 31, 2024 | 81.04 Mn |
| Dec 31, 2023 | 59.68 Mn |
| Sep 30, 2023 | 61.11 Mn |
| Jun 30, 2023 | 59.84 Mn |
| Mar 31, 2023 | 56.33 Mn |
| Dec 31, 2022 | 51.98 Mn |
| Sep 30, 2022 | 51.80 Mn |
| Jun 30, 2022 | 51.68 Mn |
| Mar 31, 2022 | 51.60 Mn |
| Dec 31, 2021 | 50.90 Mn |
| Sep 30, 2021 | 51.32 Mn |